Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (151-160 of 371) with videos related to

Pageof 38
Sort By:
Anticancer Research|June 4, 2021
The SOX2 Status of Disseminated Tumor Cells in Breast Cancer Patients Treated With Neoadjuvant ChemotherapyNatalia Krawczyk, Kathrin Janowski, Maggie Banys-Paluchowski, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 6, 2023
A workflow for the enrichment, the identification, and the isolation of non-apoptotic single circulating tumor cells for RNA sequencing analysisAnna Abramova, Mahdi Rivandi, Liwen Yang, et al.
Anticancer Research|October 23, 2009
HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumorNatalia Krawczyk, Malgorzata Banys, Hans Neubauer, et al.
Archives of Gynecology and Obstetrics|May 1, 2009
Mammotome versus ATEC: a comparison of two breast vacuum biopsy techniques under sonographic guidanceMarkus Hahn, Karl Oliver Kagan, Katja Claudia Siegmann, et al.
Oncology Reports|July 29, 2010
Evaluation of ERalpha, PR and ERbeta isoforms in neoadjuvant treated breast cancerMartin Wurster, Alexandra Ruoff, Christoph Meisner, et al.
Breast Care (Basel, Switzerland)|May 14, 2020
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept RevisitedChristiane Matuschek, Carolin Nestle-Kraemling, Thorsten Kühn, et al.
BMC Cancer|June 5, 2014
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patientsNatalia Krawczyk, Andreas Hartkopf, Malgorzata Banys, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 13, 2012
Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cellsXiangyan Ruan, Helen Schneck, Silke Schultz, et al.
Plos One|December 24, 2015
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast CancerHelen Schneck, Berthold Gierke, Frauke Uppenkamp, et al.
Breast Cancer Research and Treatment|April 2, 2011
Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breastMalgorzata Banys, Ines Gruber, Natalia Krawczyk, et al.
Pageof 38

Showing results (151-160 of 371) with videos related to

Sort By:
Pageof 38
Anticancer Research|June 4, 2021
The SOX2 Status of Disseminated Tumor Cells in Breast Cancer Patients Treated With Neoadjuvant ChemotherapyNatalia Krawczyk, Kathrin Janowski, Maggie Banys-Paluchowski, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 6, 2023
A workflow for the enrichment, the identification, and the isolation of non-apoptotic single circulating tumor cells for RNA sequencing analysisAnna Abramova, Mahdi Rivandi, Liwen Yang, et al.
Anticancer Research|October 23, 2009
HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumorNatalia Krawczyk, Malgorzata Banys, Hans Neubauer, et al.
Archives of Gynecology and Obstetrics|May 1, 2009
Mammotome versus ATEC: a comparison of two breast vacuum biopsy techniques under sonographic guidanceMarkus Hahn, Karl Oliver Kagan, Katja Claudia Siegmann, et al.
Oncology Reports|July 29, 2010
Evaluation of ERalpha, PR and ERbeta isoforms in neoadjuvant treated breast cancerMartin Wurster, Alexandra Ruoff, Christoph Meisner, et al.
Breast Care (Basel, Switzerland)|May 14, 2020
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept RevisitedChristiane Matuschek, Carolin Nestle-Kraemling, Thorsten Kühn, et al.
BMC Cancer|June 5, 2014
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patientsNatalia Krawczyk, Andreas Hartkopf, Malgorzata Banys, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 13, 2012
Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cellsXiangyan Ruan, Helen Schneck, Silke Schultz, et al.
Plos One|December 24, 2015
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast CancerHelen Schneck, Berthold Gierke, Frauke Uppenkamp, et al.
Breast Cancer Research and Treatment|April 2, 2011
Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breastMalgorzata Banys, Ines Gruber, Natalia Krawczyk, et al.
Pageof 38